Leslie A. McDonell
Leslie McDonell provides strategic counseling on the procurement and protection of intellectual property in the pharmaceutical, biotechnology, and medical device industries. She coordinates worldwide patent portfolio strategies, evaluates and analyzes competitors' patent positions around the world, and advises and renders opinions on issues of patentability, inventorship, validity, claim scope, infringement, and freedom to operate. She has extensive experience in due diligence investigations, pre-Orange Book analyses, and pre-litigation analyses.
Ms. McDonell has represented clients before the U.S. Patent and Trademark Office (USPTO) in patent appeals, interferences, reissues, reexaminations, and inter partes reviews. Her U.S. litigation experience includes representation of both plaintiffs and defendants in biotechnology and pharmaceutical cases.
In addition, she has prepared and prosecuted patent applications throughout the world and has been involved in opposition and appeal proceedings in numerous countries and at the European Patent Office (EPO). Her experience includes immunology, virology, and molecular and cellular biology, including antibody technology, gene cloning and expression, gene therapy, vaccines and diagnostics, inflammatory and autoimmune disease therapies, cancer therapies, and small molecule pharmaceuticals.
Ms. McDonell is a frequent guest speaker on the affirmative use of and best defense to inter partes reexamination and inter partes reviews. She has extensively studied and is a guest speaker on the impact of the America Invents Act on the biotechnology and pharmaceutical industries. In addition, she is a regular contributor to International Chamber of Commerce's IP publication Current and Emerging Intellectual Property Issues for Business: A Roadmap for Business and Policy Makers.
- Chiron v. Eli Lilly and Vertex Pharmaceuticals (N.D. Cal.) Represented Eli Lilly against charges of infringement in the development of an HCV small molecule therapeutic in N.D. California resulting in a favorable settlement.
- Schering Corporations v. American Home Products Corp. (D. N.J.) Represented American Home Products/Wyeth in litigation involving loratadine products.
- Participated in actions by Biogen against Medeva for infringement of patents covering hepatitis B antigens in the U.K. Patent Court, Court of Appeals, and House of Lords. Also assisted in the successful defense against opposition of these same patents at the EPO's Technical Board of Appeals.
- Represented Institut Pasteur in a series of inter partes reexaminations of patents involving homologous recombination technology.
- Successfully appealed USPTO decisions on key patent applications for Syntonix Pharmaceuticals and University of Edinburgh.
- Mayo v. Prometheus (U.S. Sup. Ct.). Coauthored amicus brief to U.S. Supreme Court on behalf of the American Intellectual Property Law Association.
- Represented Biogen, Genetics Institute, Wyeth, and Creative BioMolecules in interferences involving molecular biology inventions.
- Served as judicial extern to the Honorable Judith N. Keep of the Southern District of California, 1988.
- Pro Bono representation of disabled veterans in appeals of adverse decisions by the Veterans Administration.
- Former research associate at University of Chicago's Michael Reese Hospital, concentrating on the study of the molecular control of epithelial transport and proton chemistry, 1984-1985.
- Listed in LMG Life Sciences as an Intellectual Property: Life Sciences Star, 2012.
- Recognized as a leader in patent counseling in the field of life sciences in the U.S. by Practical Law Company’s Which Lawyer, 2010.
- Listed in Massachusetts Super Lawyers, 2007; featured as a rising star, 2005.
- BIO Intellectual Property Counsels' Committee
- American Intellectual Property Law Association
- American Bar Association (subcommittee chair, Intellectual Property Law Committee)
- Boston Bar Association (subcommittee chair, Intellectual Property Section)
- Boston Patent Law Association
- Massachusetts Biotechnology Council
Coauthor. "The ICC Intellectual Property Roadmap for Business and Policymakers," International Chamber of Commerce, 2012.
Coauthor. "From Clones to Claims, The European Patent Office's Case Law on the Patentability of Biotechnology Inventions in Comparison to the United States and Japanese Practice," Heymanns, 2012.